Page Translations

医疗保健

For over five decades, Ropes & Gray's nationally recognized health care law practice has guided market-leading health care organizations and investors in navigating regulatory compliance, managing risk, and capitalizing on opportunities. We provide strategic advice on transformative deals, complex regulatory challenges, and high-stakes litigation and enforcement matters, bringing clarity and commercial judgment to a dynamic industry.

Jump to:
Services
Who We Serve
Our health care lawyers provide comprehensive legal counsel to a diverse range of stakeholders across the industry.

Recognition & Awards

The strength and consistency of our health care practice are recognized by numerous leading publications and independent rankings.

  • Band 1 Elite Health Care Nationwide Practice—Chambers USA, 2025
  • Health Care Practice Group of the Year—Law360, 2024 and five of the previous six years
  • Corporate Legal Department of the Year, Health Care—The American Lawyer, 2024, 2022, and 2020

Insights & Tools

Ropes & Gray delivers insight beyond traditional legal advice, offering forward-looking resources and first-to-market tools.

Health Care Transactions Laws: Learn more about state and federal legislation related to health care transactions.

Health AI: State Laws & Compliance: Learn more about state and federal laws and orders affecting AI developers, and payors and providers using AI.

Featured Health Care Videos

Watch Ropes & Gray’s health care forecast of 2026 key market trends and regulatory developments here.

Watch Ropes & Gray partner Christine Moundas discusses three cutting-edge digital health and health data issues that will impact the healthcare and life sciences industries in 2026.

Watch Ropes & Gray partner Adrianne Ortega discusses how proactive, strategic planning enables organizations to navigate the increasingly complex regulatory review landscape for 2026 healthcare transactions.

Watch Ropes & Gray partner Margaux Hall discusses legal, policy, and political trends that will shape drug pricing and the pharmaceutical industry in 2026.

Watch Ropes & Gray partner Christina Bergeron discuss the sustained investment interest in medical device companies in 2026 and the key risk factors to consider in deals. 

Watch Ropes & Gray partner David Peloquin discuss new U.S. data-sharing restrictions with “countries of concern,” including China, and the implications for a globally integrated health care industry.

 

Watch Ropes & Gray partner Brett Friedman discuss policy, oversight, and AI trends that will impact the healthcare industry in 2026.

Takeaways from the 2026 J.P. Morgan Healthcare Conference

Neill Jakobe, Vice Chairman of Ropes & Gray, sat down with Deirdre Bolton to discuss his outlook for the healthcare and life sciences deal environment.
Learn More
An excellent firm with good, talented people who have a strong work ethic when it comes to supporting their clients.
Health Care Client, Chambers USA